Hydase Injection
Name: Hydase Injection
Patient Counseling Information
Important Precautions Regarding Hydase™
Instruct patient that Hydase™ is being used to increase the dispersion and absorption of fluids or other injected drugs, as appropriate to the intended use.
What Patients Should Know About Adverse Reactions
The most frequently reported adverse reactions have been mild local injection site reactions such as redness, swelling, itching, or pain.
Anaphylactic-like reactions, and allergic reactions, such as hives, have been reported rarely in patients receiving hyaluronidases.
Patients Should Inform Their Doctors If Taking Other Medications
You may not receive furosemide, the benzodiazepines, phenytoin, dopamine and/or alpha agonists with Hydase™. These medications have been found to be incompatible with hyaluronidase.
If you are taking salicylates (e.g., aspirin), steroids (e.g., cortisone or estrogens) or antihistamines your doctor may need to prescribe larger amounts of hyaluronidase for equivalent dispersing effect.
AKORN
Manufactured by: Akorn, Inc.
Lake Forest, IL 60045
HD00N Rev. 10/15
Principal Display Panel Text for Container Label:
NDC 17478-560-01
Hydase™
(hyaluronidase
injection) Bovine,
150 USP Units/mL
1 mL
Single-Use Vial
Rx only
Not recommended
for IV use.
Principal Display Panel Text for Carton Label:
NDC 17478-560-01
Hydase™
(hyaluronidase
injection) Bovine,
150 USP Units/mL
1 mL
Single-Use Vial
Rx only
Akorn Logo
| HYDASE hyaluronidase injection, solution | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| Labeler - Akorn, Inc. (062649876) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Akorn, Inc | 063434679 | PACK(17478-560), LABEL(17478-560) | |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Akorn, Inc. | 155135783 | MANUFACTURE(17478-560), ANALYSIS(17478-560), STERILIZE(17478-560) | |